Posted: 2024-08-11 19:00:00

Nuheara’s earbuds are known for their extra features such as personalised sound and speech enhancement. In January, Miller was on the ground in Las Vegas showcasing Nuheara’s new earbuds at the world’s largest consumer electronics show, CES.

“Nuheara’s next-generation hearing medical device featuring a single chip solution, means reduced size and increased performance to meet, and some instances exceed, the performance of much more expensive products from the five global hearing aid manufacturers,” he said at the time.

“Through this single chip solution, Nuheara is progressing multiple opportunities to supply interested OEMs with their own branded solutions, further increasing our revenue streams. The demonstration of our next gen product at CES 2024 – which was previewed to OEMs under a non-disclosure agreement – was incredibly well received.

“It was great to also spend time on the ground meeting our customers in Walmart and Target and demonstrating our leading Over-the-Counter (OTC) medical hearing aids.”

Nuheara is based in Perth and in 2016 released its flagship product, IQbuds, then listing on the ASX the same year through a reverse takeover of Wild Acre Metals. It became the first consumer wearables technology to list on the ASX.

Loading

Nuheara in 2019 was on the receiving end of a takeover bid by South Korean electronics giant Samsung, which lobbed an $84 million acquisition offer for the company when its shares were trading at 7¢. Samsung reportedly made multiple conditions in its offer, including that Nuheara’s board provide shareholders with a unanimous recommendation for the offer, and that the company divest fully from its mining interests.

Samsung then backed out of the deal at the last minute, reportedly because it realised the deal would need to be disclosed to the market.

Nuheara’s managing director, Justin Miller, and KPMG administrator Martin Jones were approached for comment.

The Business Briefing newsletter delivers major stories, exclusive coverage and expert opinion. Sign up to get it every weekday morning.

View More
  • 0 Comment(s)
Captcha Challenge
Reload Image
Type in the verification code above